Skip to main content
Clinical Trials/NCT04376892
NCT04376892
Completed
Not Applicable

The Effect of Exercise Capacity on Quality of Life in COPD Patients

Izmir Katip Celebi University0 sites516 target enrollmentJanuary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Copd
Sponsor
Izmir Katip Celebi University
Enrollment
516
Primary Endpoint
Quality of life questionnaire
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

COPD patients will be examined in 4 groups according to their walking distance. Patients walking under 150 meters will be determined as Group 1, those walking between 150-249 meters will be Group 2, those walking between 250-349 meters will be selected as Group 3, and patients with COPD who walk 350 and above will be determined as Group 4. The groups were compared in terms of quality of life, psychological symptoms and dyspnea.

Detailed Description

Quality of life affects the mortality rate independently in patients with COPD. The treatment applied in COPD does not stop the decrease in lung function, nor does it prolong the survival time. Spirometric evaluations to determine the severity of the disease are not sufficient to explain the perception of patients and their adaptation to their diseases. Therefore, evaluating the quality of life has become an important measure of treatment in COPD patients. Quality of life measurements should be done to minimize the effect of the disease, to help patients better cope with the consequences of an incurable long-term condition, and to determine modifiable factors. Identifying modifiable factors; in personalized treatment adopted in airway diseases in recent years; it is important to be able to apply appropriate pharmacological and non-pharmacological treatments Our aim is to exercise capacity in COPD patients; firstly to investigate the effect on quality of life, then to determine the relationship between emergency admission and hospitalization, dyspnea, psychological symptoms.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
May 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Izmir Katip Celebi University
Responsible Party
Principal Investigator
Principal Investigator

Ilknur Naz

Assoc. Prof.

Izmir Katip Celebi University

Eligibility Criteria

Inclusion Criteria

  • COPD patients completed all tests and qustionnaires

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Quality of life questionnaire

Time Frame: 20 minutes

St. George Respiratory Questionnaire

Secondary Outcomes

  • Dyspnea Severity(5 minutes)
  • Respiratory Function(20 minutes)
  • Anxiety Depression(20 minutes)

Similar Trials